Atorvastatin calcium and Red cell distribution width increased - a phase IV clinical study of FDA data

Summary:

Red cell distribution width increased is reported as a side effect among people who take Atorvastatin calcium (atorvastatin calcium), especially for people who are male, 40-49 old, have been taking the drug for 1 - 2 years also take Valproate Sodium, and have Dyslipidaemia.

The phase IV clinical study analyzes which people have Red cell distribution width increased when taking Atorvastatin calcium. It is created by eHealthMe based on reports of 72,753 people who have side effects when taking Atorvastatin calcium from the FDA, and is updated regularly.

What is Atorvastatin calcium?

Atorvastatin calcium has active ingredients of atorvastatin calcium. It is often used in high blood cholesterol. eHealthMe is studying from 77,309 Atorvastatin calcium users. Check the latest studies of Atorvastatin calcium.

What is Red cell distribution width increased?

Red cell distribution width increased is found to be associated with 607 drugs and 653 conditions by eHealthMe. Check the latest studies of Red cell distribution width increased.

On Jul, 06, 2026

72,753 people reported to have side effects when taking Atorvastatin calcium.
Among them, 53 people (0.07%) have Red cell distribution width increased.

Could Atorvastatin calcium cause Red cell distribution width increased?

Among these 53 people:

How long have people been on Atorvastatin calcium when they have Red cell distribution width increased? *

What is the gender of people who have Red cell distribution width increased when taking Atorvastatin calcium? *

female: 35.56 %
male: 64.44 %

What is the age of people who have Red cell distribution width increased when taking Atorvastatin calcium? *

What are other drugs people take besides Atorvastatin calcium? *

What are other side effects people have besides Red cell distribution width increased? *

Haemoglobin Decreased: 32 people, 60.38%
Red Blood Cell Count Decreased: 31 people, 58.49%
Thrombocytopenia (decrease of platelets in blood): 23 people, 43.40%
Haematocrit Decreased: 22 people, 41.51%
Blood Urea Increased: 20 people, 37.74%
Troponin T Increased: 19 people, 35.85%
Neutrophil Count Increased (excess than normal number of neutrophil a type of blood cell): 17 people, 32.08%
Blood Albumin Decreased: 16 people, 30.19%
Blood Creatinine Increased: 16 people, 30.19%
Dyspnea (difficult or laboured breathing): 14 people, 26.42%

What are the existing conditions these people have? *

Type 1 Diabetes: 8 people, 15.09%
Schizoaffective Disorder (a mental disorder characterized by disordered thought): 8 people, 15.09%
Dyslipidaemia (abnormal amount of lipids): 8 people, 15.09%
Insomnia (sleeplessness): 5 people, 9.43%
Hereditary Neuropathic Amyloidosis (hereditary- diseases resulting from abnormal deposition of certain proteins (amyloid) in various bodily areas by problems with signals from the nerves): 5 people, 9.43%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 4 people, 7.55%
Sleep Disorder: 3 people, 5.66%
Pain: 3 people, 5.66%
Chest Pain: 2 people, 3.77%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 3.77%

* Approximation only. Some reports may have incomplete information.

Do you take Atorvastatin calcium and have Red cell distribution width increased?

- Check whether Red cell distribution width increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Atorvastatin calcium:

Atorvastatin calcium (77,309 reports)

Browse all side effects of Atorvastatin calcium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Red cell distribution width increased:

Red cell distribution width increased (607 drugs)

Browse all the conditions that are associated with Red cell distribution width increased:

Red cell distribution width increased (653 conditions)

Related publications that referenced our studies

Proti? D, Balti? S, Stupar N, Pavlov-Dolijanovi? S, Mugo?a S, Todorovi? Z, "A case of myositis with immunological background associated with statin use", Open Medicine, 2014 Oct .
Goldie MP, "Atorvastatin: a new treatment for periodontal disease?", , 2012 Jan .
Proti? D, Balti? S, Stupar N, Pavlov-Dolijanovi? S, Mugo?a S, Todorovi? Z, "A case of myositis with immunological background associated with statin use", Open Medicine, 2014 Oct .
Goldie MP, "Atorvastatin: a new treatment for periodontal disease?", , 2012 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on atorvastatin calcium (the active ingredients of Atorvastatin calcium) and Atorvastatin calcium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.